Enochian BioSciences regains Nasdaq compliance by filing pending reports

Mar. 13, 2023 9:41 AM ETEnochian Biosciences Inc. (ENOB)By: Ahmed Farhath, SA News Editor1 Comment

  • Enochian BioSciences (NASDAQ:ENOB) on Monday said the company has achieved full compliance with Nasdaq filing requirements.

  • The company said it regained compliance by filing its annual report on form 10-K on February 27, 2023, followed by the quarterly reports on forms 10-Q for the quarters ending September 30, 2022 and December 31, 2022 on March 7th and March 9th, 2023, respectively. 

  • Press Release.

Recommended For You

Comments (1)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.